• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突变型 p53 通过染色体不稳定诱导的细胞质 DNA 反应获得致癌功能。

Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response.

机构信息

Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Department of Head and Neck Surgery, Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital & Institute, 100142, Beijing, China.

出版信息

Nat Commun. 2024 Jan 2;15(1):180. doi: 10.1038/s41467-023-44239-2.

DOI:10.1038/s41467-023-44239-2
PMID:38167338
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10761733/
Abstract

Inactivating TP53 mutations leads to a loss of function of p53, but can also often result in oncogenic gain-of-function (GOF) of mutant p53 (mutp53) proteins which promotes tumor development and progression. The GOF activities of TP53 mutations are well documented, but the mechanisms involved remain poorly understood. Here, we study the mutp53 interactome and find that by targeting minichromosome maintenance complex components (MCMs), GOF mutp53 predisposes cells to replication stress and chromosomal instability (CIN), leading to a tumor cell-autonomous and cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING)-dependent cytosolic DNA response that activates downstream non-canonical nuclear factor kappa light chain enhancer of activated B cell (NC-NF-κB) signaling. Consequently, GOF mutp53-MCMs-CIN-cytosolic DNA-cGAS-STING-NC-NF-κB signaling promotes tumor cell metastasis and an immunosuppressive tumor microenvironment through antagonizing interferon signaling and regulating genes associated with pro-tumorigenic inflammation. Our findings have important implications for understanding not only the GOF activities of TP53 mutations but also the genome-guardian role of p53 and its inactivation during tumor development and progression.

摘要

TP53 基因突变导致 p53 功能丧失,但也常常导致突变型 p53(mutp53)蛋白的致癌获得性功能(GOF),从而促进肿瘤的发生和发展。TP53 基因突变的 GOF 活性已有充分的文献记载,但相关机制仍知之甚少。在这里,我们研究了 mutp53 互作组,发现通过靶向微小染色体维持复合物成分(MCMs),GOF mutp53 使细胞易发生复制应激和染色体不稳定(CIN),导致肿瘤细胞自主和环鸟苷酸-腺苷酸合成酶(cGAS)-干扰素基因刺激物(STING)依赖性细胞质 DNA 反应,激活下游非经典核因子κB 轻链增强子激活 B 细胞(NC-NF-κB)信号。因此,GOF mutp53-MCMs-CIN-cytosolic DNA-cGAS-STING-NC-NF-κB 信号通过拮抗干扰素信号和调节与促肿瘤炎症相关的基因,促进肿瘤细胞转移和免疫抑制性肿瘤微环境。我们的发现不仅对理解 TP53 基因突变的 GOF 活性,而且对 p53 的基因组保护作用及其在肿瘤发生和发展过程中的失活具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0271/10761733/5489c50b5b10/41467_2023_44239_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0271/10761733/52f4f186a310/41467_2023_44239_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0271/10761733/6044e78f87d0/41467_2023_44239_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0271/10761733/bc6e7fa1c5b3/41467_2023_44239_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0271/10761733/9c2cbc2ac415/41467_2023_44239_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0271/10761733/b0cd5d7b6352/41467_2023_44239_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0271/10761733/5489c50b5b10/41467_2023_44239_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0271/10761733/52f4f186a310/41467_2023_44239_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0271/10761733/6044e78f87d0/41467_2023_44239_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0271/10761733/bc6e7fa1c5b3/41467_2023_44239_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0271/10761733/9c2cbc2ac415/41467_2023_44239_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0271/10761733/b0cd5d7b6352/41467_2023_44239_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0271/10761733/5489c50b5b10/41467_2023_44239_Fig6_HTML.jpg

相似文献

1
Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response.突变型 p53 通过染色体不稳定诱导的细胞质 DNA 反应获得致癌功能。
Nat Commun. 2024 Jan 2;15(1):180. doi: 10.1038/s41467-023-44239-2.
2
Role of micronucleus-activated cGAS-STING signaling in antitumor immunity.微核激活的 cGAS-STING 信号通路在抗肿瘤免疫中的作用。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 Jan 26;53(1):25-34. doi: 10.3724/zdxbyxb-2023-0485.
3
Gain-of-function mutant p53 in cancer progression and therapy.抑癌基因 p53 功能获得性突变与癌症的发生发展及治疗
J Mol Cell Biol. 2020 Sep 1;12(9):674-687. doi: 10.1093/jmcb/mjaa040.
4
p53 engages the cGAS/STING cytosolic DNA sensing pathway for tumor suppression.p53 通过激活 cGAS/STING 细胞质 DNA 感应通路来抑制肿瘤。
Mol Cell. 2023 Jan 19;83(2):266-280.e6. doi: 10.1016/j.molcel.2022.12.023. Epub 2023 Jan 12.
5
Chromosomal instability drives metastasis through a cytosolic DNA response.染色体不稳定性通过细胞质 DNA 反应驱动转移。
Nature. 2018 Jan 25;553(7689):467-472. doi: 10.1038/nature25432. Epub 2018 Jan 17.
6
Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation.通过诱导 p53 乙酰化靶向密码子 158 p53 突变型癌症。
Nat Commun. 2020 Apr 29;11(1):2086. doi: 10.1038/s41467-020-15608-y.
7
Interaction between the SFTSV envelope glycoprotein Gn and STING inhibits the formation of the STING-TBK1 complex and suppresses the NF-κB signaling pathway.发热伴血小板减少综合征病毒包膜糖蛋白 Gn 与 STING 相互作用抑制 STING-TBK1 复合物的形成并抑制 NF-κB 信号通路。
J Virol. 2024 Mar 19;98(3):e0181523. doi: 10.1128/jvi.01815-23. Epub 2024 Feb 29.
8
DNA sensing in cancer: Pro-tumour and anti-tumour functions of cGAS-STING signalling.癌症中的 DNA 感应:cGAS-STING 信号的促肿瘤和抗肿瘤功能。
Essays Biochem. 2023 Sep 28;67(6):905-918. doi: 10.1042/EBC20220241.
9
Gain of function mutant p53 protein activates AKT through the Rac1 signaling to promote tumorigenesis.功能获得性突变 p53 蛋白通过 Rac1 信号激活 AKT 以促进肿瘤发生。
Cell Cycle. 2020 Jun;19(11):1338-1351. doi: 10.1080/15384101.2020.1749790. Epub 2020 Apr 10.
10
Pontin, a new mutant p53-binding protein, promotes gain-of-function of mutant p53.Pontin,一种新型突变型p53结合蛋白,可促进突变型p53的功能获得。
Cell Death Differ. 2015 Nov;22(11):1824-36. doi: 10.1038/cdd.2015.33. Epub 2015 Apr 10.

引用本文的文献

1
Comprehensive analysis of disulfidoptosis-related genes reveals molecular heterogeneity and key regulators in retinoblastoma progression.与二硫键介导的细胞凋亡相关基因的综合分析揭示了视网膜母细胞瘤进展中的分子异质性和关键调节因子。
Transl Pediatr. 2025 Jul 31;14(7):1454-1470. doi: 10.21037/tp-2024-596. Epub 2025 Jul 28.
2
Unlocking the therapeutic potential of the STING signaling pathway in anti-tumor treatment.释放STING信号通路在抗肿瘤治疗中的治疗潜力。
Clin Exp Med. 2025 Aug 12;25(1):290. doi: 10.1007/s10238-025-01838-1.
3
Sensitizing Immune-Refractory Ovarian Tumors via p53 Mutation-Tailored Immunotherapy.

本文引用的文献

1
Non-cell-autonomous cancer progression from chromosomal instability.非细胞自主性的染色体不稳定性癌症进展。
Nature. 2023 Aug;620(7976):1080-1088. doi: 10.1038/s41586-023-06464-z. Epub 2023 Aug 23.
2
Ordered and deterministic cancer genome evolution after p53 loss.p53 失活后有序且确定的癌症基因组进化。
Nature. 2022 Aug;608(7924):795-802. doi: 10.1038/s41586-022-05082-5. Epub 2022 Aug 17.
3
Activating STING1-dependent immune signaling in mutant and wild-type acute myeloid leukemia.在突变型和野生型急性髓系白血病中激活 STING1 依赖性免疫信号通路。
通过p53突变定制免疫疗法使免疫难治性卵巢肿瘤致敏
bioRxiv. 2025 Jun 27:2025.06.23.661120. doi: 10.1101/2025.06.23.661120.
4
Mutant p53 as a Therapeutic Target: The Report of Its Death Was an Exaggeration.突变型p53作为治疗靶点:关于其失活的报道言过其实。
Int J Mol Sci. 2025 Jul 4;26(13):6446. doi: 10.3390/ijms26136446.
5
Evaluation of two algorithms measuring homologous recombination deficiency status in prognostic assessment for treatment-naïve non-small cell lung cancer.两种评估初治非小细胞肺癌预后的同源重组缺陷状态测量算法的比较
Chin J Cancer Res. 2025 Jun 30;37(3):352-364. doi: 10.21147/j.issn.1000-9604.2025.03.05.
6
A cancer persistent DNA repair circuit driven by MDM2, MDM4 (MDMX), and mutant p53 for recruitment of MDC1 and 53BP1 on chromatin.由MDM2、MDM4(MDMX)和突变型p53驱动的癌症持续性DNA修复回路,用于在染色质上募集MDC1和53BP1。
Nucleic Acids Res. 2025 Jul 8;53(13). doi: 10.1093/nar/gkaf627.
7
Enhancing the therapeutic potential of FDA-approved ifosfamide and 5-fluorouracil through rational chemical modifications for endometrial cancer treatment.通过合理的化学修饰提高美国食品药品监督管理局批准的异环磷酰胺和5-氟尿嘧啶治疗子宫内膜癌的潜力。
Med Oncol. 2025 Jun 25;42(8):281. doi: 10.1007/s12032-025-02821-2.
8
Targeting metastasis in paediatric bone sarcomas.靶向治疗小儿骨肉瘤的转移
Mol Cancer. 2025 May 29;24(1):153. doi: 10.1186/s12943-025-02365-z.
9
Establishment of a chemoresistant laryngeal cancer cell model to study chemoresistance and chemosensitization responses via transcriptomic analysis and a tumor-on-a-chip platform.通过转录组分析和芯片肿瘤平台建立化疗耐药喉癌细胞模型以研究化疗耐药性和化疗增敏反应。
Bioeng Transl Med. 2025 Jan 22;10(3):e10741. doi: 10.1002/btm2.10741. eCollection 2025 May.
10
Oncogenic and teratogenic effects of , an inflammation-prone mouse model of the human hotspot mutant .人类热点突变体的一种易发生炎症的小鼠模型的致癌和致畸作用。 (备注:原文中“Oncogenic and teratogenic effects of ”后面缺少具体内容,翻译只能根据现有内容尽量准确表述)
Elife. 2025 Apr 14;13:RP102434. doi: 10.7554/eLife.102434.
Proc Natl Acad Sci U S A. 2022 Jul 5;119(27):e2123227119. doi: 10.1073/pnas.2123227119. Epub 2022 Jun 27.
4
cGAS-STING drives the IL-6-dependent survival of chromosomally instable cancers.cGAS-STING 驱动染色体不稳定癌症中依赖 IL-6 的存活。
Nature. 2022 Jul;607(7918):366-373. doi: 10.1038/s41586-022-04847-2. Epub 2022 Jun 15.
5
Novel protein contact points among TP53 and minichromosome maintenance complex proteins 2, 3, and 5.TP53 与微小染色体维持复合物蛋白 2、3、5 之间的新蛋白接触点。
Cancer Med. 2022 Dec;11(24):4989-5000. doi: 10.1002/cam4.4805. Epub 2022 May 14.
6
Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma.向浸润性乳腺癌的转变与肿瘤基质的结构和成分的进行性变化有关。
Cell. 2022 Jan 20;185(2):299-310.e18. doi: 10.1016/j.cell.2021.12.023.
7
The adaptive immune system is a major driver of selection for tumor suppressor gene inactivation.适应性免疫系统是肿瘤抑制基因失活选择的主要驱动因素。
Science. 2021 Sep 17;373(6561):1327-1335. doi: 10.1126/science.abg5784. Epub 2021 Sep 16.
8
Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis.上皮细胞对炎症的记忆在限制组织损伤的同时促进了胰腺肿瘤的发生。
Science. 2021 Sep 17;373(6561):eabj0486. doi: 10.1126/science.abj0486.
9
Acquisition of aneuploidy drives mutant p53-associated gain-of-function phenotypes.获得非整倍体导致突变型 p53 相关获得性功能表型。
Nat Commun. 2021 Aug 31;12(1):5184. doi: 10.1038/s41467-021-25359-z.
10
Transglutaminase 2 promotes tumorigenicity of colon cancer cells by inactivation of the tumor suppressor p53.转谷氨酰胺酶 2 通过失活肿瘤抑制因子 p53 促进结肠癌细胞的致瘤性。
Oncogene. 2021 Jun;40(25):4352-4367. doi: 10.1038/s41388-021-01847-w. Epub 2021 Jun 8.